India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh
Unapproved drops for dry eyes pose risks: Govt
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward
Govt highlights multi-layer framework to curb misleading advertisements
Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal
Study finds rising resistance to a last-resort antibiotic in Africa
Patna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
Pharma Company Bus Overturns in Miyapur, 10 Employees Injured, Probe Underway
India regulator asks states to implement uniform drug licensing norms to end quality gapsLegs after 15 years of limp, thanks to hip replacement surgery
New Delhi: Mr. Anutosh Mishra, 53, was suffering from Ankylosing Spondylitis, a form of arthritis that primarily affects the spine. As a result he, a bank employee, had to endure…
What are you smoking? Study to monitor pollutants on the ground
NEW DELHI: An IIT-Kanpur source apportionment study for Delhi is being planned with real-time analysis to provide a better understanding of the sources of pollution plaguing the capital. Experts at…
Doctors counter govt statement that they work for 40 hrs a week
New Delhi: Doctors have countered a government statement that they work for a maximum of 40 hours a week, claiming that their work hours often add up to as much…
Drug companies turn to China, Japan after pricing pressure in west
HYDERABAD: Increasing price pressures in the North American market, which accounts for nearly a third of India’s pharmaceutical exports, is prompting domestic drug makers to explore avenues in new markets…
Sterling Biotech receives NBWs in Rs 8,100-crore bank loan fraud case
A Delhi court Saturday issued open-ended non-bailable warrants (NBWs) against four directors of a Gujarat pharma firm in a Rs 8,100-crore money laundering probe case. Additional Sessions Judge Satish Kumar…
Health ministry mulled compulsory licencing of rare disease drugs
NEW DELHI: The health ministry was actively mulling compulsory licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the department of pharmaceuticals abruptly issued an order exempting…
Bristol-Myers Squibb buying Celgene in USD 74 bn deal
Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about USD 74 billion. Shareholders of Celgene Corp, based in Summit, New Jersey, will receive one share of the…
Endeavour of govt is to provide affordable quality healthcare for all: Gowda
New Delhi: The government Thursday said it endeavours to provide affordable quality healthcare for all while also working to boost the domestic pharmaceutical sector through ‘Make in India’. As part…
Alembic Pharma gets USFDA nod for Parkinson’s treatment drug
New Delhi: Drug firm Alembic Pharmaceuticals Thursday said it has received approval from the US health regulator for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The…
Biopharma Co Vyome gets Rs 154 crore from investors
New Delhi: Vyome Therapeutics, a biopharmaceutical firm focused on developing dermatology products, has raised $22 million (about Rs 154 crore) in a fresh round of funding led by Mumbai based…